(Nov. 3, 2023) – The Health Resources and Services Administration is reinstating a requirement for hospitals in the 340B Drug Pricing Program to register their off-site outpatient departments, known as child sites, with the 340B Office of Pharmacy Affairs to access 340B pricing. HRSA previously provided flexibility regarding the registration of child sites during the COVID-19 public health emergency. The notice includes the following instructions:
"To be registered and continue to be listed in OPAIS as participating in the 340B Program, a hospital-covered entity's off-site, outpatient facility must (1) be listed as reimbursable on the hospital's most recently filed Medicare Cost Report and (2) have associated outpatient costs and charges on the most recently filed Medicare Cost Report."
Hospitals will have 90 days from the publication date to meet the notice requirements.
--Shannan Flach